An interdisciplinary team in San Francisco uses acupressure, massage, counseling and other methods, as well as medicine, to help kids get relief from chronic pain. But such pediatric centers are rare.
A federal agency issued a proposed rule Friday that rolls back Obama-era protections for transgender patients. Advocates for transgender people say the rule leaves them vulnerable to discrimination.
The rule strengthens protections for health care providers, unwilling to provide services like abortions. Critics say it could put women’s health in danger.
The Senate Finance Committee will hear Tuesday from executives from the biggest pharmacy benefit managers. Confidential rebates paid to the PBMs are expected to draw scrutiny.
As Congressional lawmakers continue to turn up the heat on drugmakers, insurers and middlemen over the price of many medicines, one player says it will limit patients’ share of the cost of insulin.
A federal judge has struck down a Medicaid work requirement in Arkansas and Kentucky. This is a major blow to the Trump administration’s vision for the health insurance program for low-income people.
The Trump administration’s shift in a major legal case against the Affordable Care Act could lead to the reversal of the expansive law and far-reaching effects on all Americans’ health care.
The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration’s call to tie prices to what other nations pay might work better.
A little-noticed Trump administration proposal would require hospitals, doctors and insurers to post the true, negotiated price for a medical procedure or service, as opposed to the “list” price.